RI
RTW Investments Portfolio holdings
AUM
$8.12B
1-Year Est. Return
73.2%
1 Year Est. Return
+73.2%
AUM
$7.02B
AUM Growth
+$483M
(+7.4%)
Holding
78
Top Buys
| 1 | +$133M | |
| 2 | +$83.9M | |
| 3 | +$72M | |
| 4 |
Abbott
ABT
|
+$60.4M |
| 5 |
Guardant Health
GH
|
+$44.6M |
Top Sells
| 1 | +$147M | |
| 2 | +$104M | |
| 3 | +$82.3M | |
| 4 |
Alkermes
ALKS
|
+$63M |
| 5 |
Arvinas
ARVN
|
+$23.4M |
Sector Composition
| 1 | Healthcare | 99.89% |
| 2 | Financials | 0.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Quest Diagnostics
DGX
$20.3B
| $89.8M | 1.28% |
500,000
+401,003
|
|
||
27
uniQure
QURE
$1.58B
| $71.9M | 1.02% |
5,158,231
+892,803
|
|
||
28
GH Research
GHRS
$872M
| $67.5M | 0.96% |
5,540,457
+40,688
|
|
||
29
UroGen Pharma
URGN
$1.14B
| $62.3M | 0.89% |
4,543,895
+709,101
|
|
||
30
Ultragenyx Pharmaceutical
RARE
$3.23B
| $62.1M | 0.88% |
1,707,402
|
|
||
|
31
Abbott
ABT
$220B
| $60.4M | 0.86% |
+444,000
|
|
||
32
Stoke Therapeutics
STOK
$1.7B
| $58.2M | 0.83% |
5,123,525
|
|
||
33
Taysha Gene Therapies
TSHA
$1.11B
| $57.8M | 0.82% |
25,021,584
+6,233,718
|
|
||
34
Spyre Therapeutics
SYRE
$2.2B
| $54.2M | 0.77% |
3,621,996
|
|
||
|
BBNX
35
Beta Bionics
BBNX
$1.25B
| $48M | 0.68% |
3,299,191
-679
|
|
||
36
GE HealthCare
GEHC
$36.5B
| $46.4M | 0.66% |
626,000
+106,000
|
|
||
|
37
Guardant Health
GH
$13.5B
| $44.6M | 0.63% |
+856,501
|
|
||
38
CG Oncology
CGON
$3.34B
| $44.2M | 0.63% |
1,701,216
|
|
||
39
Rocket Pharmaceuticals
RCKT
$334M
| $43.3M | 0.62% |
17,687,772
|
|
||
40
Immatics
IMTX
$1.2B
| $37.5M | 0.53% |
6,970,152
+60,642
|
|
||
41
Soleno Therapeutics
SLNO
$2.58B
| $35.6M | 0.51% |
+424,408
|
|
||
42
MoonLake Immunotherapeutics
MLTX
$887M
| $35M | 0.5% |
+741,090
|
|
||
|
TEM
43
Tempus AI
TEM
$13.2B
| $25.4M | 0.36% |
400,000
|
|
||
|
LENZ
44
LENZ Therapeutics
LENZ
$855M
| $25.3M | 0.36% |
863,389
|
|
||
|
CMPS
45
Compass Pathways
CMPS
$474M
| $23M | 0.33% |
8,221,929
+2,683,761
|
|
||
46
Orchestra BioMed
OBIO
$269M
| $22.3M | 0.32% |
8,306,062
+99,900
|
|
||
|
ORKA
47
Oruka Therapeutics
ORKA
$1.35B
| $21.8M | 0.31% |
1,945,649
|
|
||
48
Neurogene
NGNE
$298M
| $20.4M | 0.29% |
1,362,456
+13,800
|
|
||
|
CNTA
49
Centessa Pharmaceuticals
CNTA
$4.21B
| $20.1M | 0.29% |
1,529,836
+1,479,836
|
|
||
|
ETNB
50
DELISTED
89bio
ETNB
| $19.3M | 0.28% |
1,967,527
|
|